3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Pain, Postoperative
5
Pain
2
Chronic Pain
2
Breast Neoplasms
2
Spinal Cord Neoplasms
1
Seizures
1
Pinealoma
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive
1
Neuralgia
1
Neoplasms
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Hot Flashes
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Cancer Patient
1
Brain Neoplasms
1
Astrocytoma
1
Acute Pain
1
Interventions
Ketamine
2
Gabapentin
2
Diclofenac
2
Anesthesia, General
2
Acetaminophen
2
Tea
1
Quality of Life
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Oxycodone
1
Minocycline
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Hydromorphone
1
Ethyl Chloride
1
Epinephrine
1
Duloxetine Hydrochloride
1
Diathermy
1
Dexmedetomidine
1
Cryotherapy
1
Bupivacaine
1
Anti-Inflammatory Agents, Non-Steroidal
1
Analgesia, Patient-Controlled
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Acute Pain
×
Pregabalin
×
Clear all
NCT01789216
2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3
Completed
450 enrolled